Kitagawa T, Owada M, Aoki K, Arai S, Oura T, Matsuda I, Igarashi Y, Tada K, Katayama S, Hashida W
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Enzyme. 1987;38(1-4):321-7. doi: 10.1159/000469222.
A method of preparation of a more palatable therapeutic formula for phenylketonuria (PKU), consisting of low-phenylalanine peptide (LPP), was reported. There were no adverse effects and, in fact, there was a reduced frequency of diarrhea in patients who received LPP formula for more than 6 months. The LPP formula can be used not only as a more palatable therapeutic milk for PKU, but also as an ingredient to make more palatable foods of low-phenylalanine content.
据报道，有一种制备更可口的苯丙酮尿症（PKU）治疗配方的方法，该配方由低苯丙氨酸肽（LPP）组成。没有不良反应，事实上，接受LPP配方超过6个月的患者腹泻频率降低。LPP配方不仅可以用作更可口的PKU治疗奶粉，还可以用作制作低苯丙氨酸含量更可口食物的成分。
